Bussolati B, Dunk C, Grohman M, Kontos C D, Mason J, Ahmed A
Department of Reproductive and Vascular Biology, The Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Am J Pathol. 2001 Sep;159(3):993-1008. doi: 10.1016/S0002-9440(10)61775-0.
The known responses of vascular endothelial growth factor (VEGF) are mediated through VEGF receptor-2 (VEGFR-2/KDR) in endothelial cells. However, it is unknown whether VEGFR-1 (Flt-1) is an inert decoy or a signaling receptor for VEGF during physiological or pathological angiogenesis. Here we report that VEGF-stimulated nitric oxide (NO) release is inhibited by blockade of VEGFR-1 and that VEGFR-1 via NO negatively regulates of VEGFR-2-mediated proliferation and promotes formation of capillary networks in human umbilical vein endothelial cells (HUVECs). Inhibition of VEGFR-1 in a murine Matrigel angiogenesis assay induced large aneurysm-like structures. VEGF-induced capillary growth over 14 days was inhibited by anti-VEGFR-2-blocking antibody as determined by reduced tube length between capillary connections (P < 0.0001) in an in vitro angiogenesis assay. In contrast, loss of VEGFR-1 activity with a neutralizing anti-VEGFR-1 antibody resulted in an increase in the accumulation of endothelial cells (P < 0.0001) and a dramatic decrease in the number of capillary connections that were restored by the addition of NO donor. Porcine aortic endothelial (PAE) cells expressing human VEGFR-1 but not VEGFR-2 plated on growth factor-reduced Matrigel rearranged into tube-like structures that were prevented by anti-VEGFR-1 antibody or a cGMP inhibitor. VEGF stimulated NO release from VEGFR-1- but not VEGFR-2-transfected endothelial cells and placenta growth factor-1 stimulated NO release in HUVECs. Blockade of VEGFR-1 increased VEGF-mediated HUVEC proliferation that was inhibited by NO donors, and potentiated by NO synthase inhibitors. These data indicate that VEGFR-1 is a signaling receptor that promotes endothelial cell differentiation into vascular tubes, in part by limiting VEGFR-2-mediated endothelial cell proliferation via NO, which seems to be a molecular switch for endothelial cell differentiation.
血管内皮生长因子(VEGF)的已知反应是通过内皮细胞中的VEGF受体-2(VEGFR-2/KDR)介导的。然而,在生理或病理血管生成过程中,VEGFR-1(Flt-1)是一个无活性的诱饵受体还是VEGF的信号受体尚不清楚。在此,我们报告VEGFR-1的阻断抑制了VEGF刺激的一氧化氮(NO)释放,并且VEGFR-1通过NO负向调节VEGFR-2介导的增殖,并促进人脐静脉内皮细胞(HUVECs)中毛细血管网络的形成。在小鼠基质胶血管生成试验中,VEGFR-1的抑制诱导了大的动脉瘤样结构。在体外血管生成试验中,通过抗VEGFR-2阻断抗体测定,VEGF诱导的14天内毛细血管生长受到抑制,这表现为毛细血管连接之间的管长度缩短(P < 0.0001)。相反,用中和性抗VEGFR-1抗体丧失VEGFR-1活性导致内皮细胞积累增加(P < 0.0001),并且毛细血管连接数量显著减少,而添加NO供体可恢复该数量。在生长因子减少的基质胶上培养的表达人VEGFR-1但不表达VEGFR-2的猪主动脉内皮(PAE)细胞重排成管状结构,抗VEGFR-1抗体或cGMP抑制剂可阻止这种重排。VEGF刺激转染VEGFR-1但不转染VEGFR-2的内皮细胞释放NO,胎盘生长因子-1刺激HUVECs释放NO。VEGFR-1的阻断增加了VEGF介导的HUVEC增殖,NO供体可抑制该增殖,而NO合酶抑制剂可增强该增殖。这些数据表明,VEGFR-1是一种信号受体,它部分通过经由NO限制VEGFR-2介导的内皮细胞增殖来促进内皮细胞分化为血管管,这似乎是内皮细胞分化的分子开关。